Nicholas Garmon
Psychiatric/Mental Health · Mountlake Terrace, WANPI 1639530785
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 208 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 25.3% of the total. Reporting peaked in 2021 at $1,765 and has fallen 83.8% since, to $286 in 2025. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 208 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$621
- Supernus Pharmaceuticals, Inc.$512
- Otsuka America Pharmaceutical, Inc.$308
- Axsome Therapeutics, Inc.$270
- Neurocrine Biosciences, Inc.$269
- plus $1K from 12 others
What the payments were for
- Food & beverage$4,185100%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 55 | $1,060 |
| AbbVie(2 entities) | 39 | $621 |
| Supernus Pharmaceuticals, Inc. | 31 | $512 |
| Otsuka America Pharmaceutical, Inc. | 21 | $308 |
| Axsome Therapeutics, Inc. | 3 | $270 |
| Neurocrine Biosciences, Inc. | 2 | $269 |
| Bausch Health US, LLC | 17 | $268 |
| Ironshore Pharmaceuticals Inc. | 13 | $264 |
| Corium, LLC | 7 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
| Avanir Pharmaceuticals, Inc. | 5 | $108 |
| Johnson & Johnson | 1 | $98 |
| Tris Pharma Inc | 2 | $35 |
| Jazz Pharmaceuticals Inc. | 2 | $30 |
| Eisai Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,196 in reported general payments places this provider in the 90th percentile of 931 psychiatric/mental health providers in Washington.
Other psychiatric/mental health in Mountlake Terrace
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
- Jennifer WilsonYakima$23K
- Kojo SarfoEllensburg$20K
- Brendan RoeVancouver$18K
- Jenna VoKent$18K
- Kelly BlissSeattle$18K
- Agnes MarambaKent$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.